◆英語タイトル：University of California Berkeley - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA904C8088
◆発行会社（調査会社）：
GlobalData
◆発行日：2018年10月
◆ページ数：43
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
Summary
University of California Berkeley (UC Berkeley), a subsidiary of University of California is an educational university that offers educational programs and research services. The university’s academic programs comprise law and economics program, legal studies; lesbian, gay, bisexual, and transgender studies, letters and science, liberal arts, linguistics, logic and the methodology of sciencebiophysics, biostatistics, buddhist studies, cognitive science, development practice, integrative biology, interdisciplinary studies, Jewish studies program, mathematics, and others. It carries out research in partnership with academic departments, institutes and centers, museums, and field stations. The university provides educational services through its colleges and schools. UC Berkeley is headquartered in Berkeley, California, the US.
University of California Berkeley – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of California Berkeley, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of California Berkeley, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
University of California Berkeley, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
MYOS RENS Technology Enters into Research Agreement with University Of California Berkley 10
Novartis Enters into Agreement with University of California 11
University of California, Berkeley Enters into Agreement with Aduro Biotech 12
Licensing Agreements 13
Excision BioTherapeutics Enters into Licensing Agreement with University of California Berkeley 13
Aduro BioTech Amends Licensing Agreement with University of California, Berkeley 14
Aduro BioTech Enters Into Licensing Agreement With University Of California, Berkeley 15
Aduro BioTech Enters into Licensing Agreement with UCB 16
University of California Berkeley – Key Competitors 17
University of California Berkeley – Key Employees 18
University of California Berkeley – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Government and Public Interest 20
Sep 26, 2018: CZ Biohub awards $13.7 million for new collaborative health research 20
Aug 16, 2018: New Approach to Fight Tuberculosis, a Leading Cause of Death Worldwide 21
Aug 02, 2018: Obesity extends duration of influenza a virus shedding 23
Jul 18, 2018: St. Baldrick’s foundation announces $19.1 million in grants to fund lifesaving childhood cancer research 24
May 14, 2018: New structure of tau protein, a key player in Alzheimer’s disease 25
Jan 29, 2018: Kenneth Rainin Foundation: $1.7 Million to Improve IBD Patient Outcomes 26
Jan 23, 2018: Damon Runyon Cancer Research Foundation awards $3M to eleven innovative early career scientists 27
Nov 06, 2017: Scientists discover potential treatment to stop glaucoma in its tracks 30
Jul 19, 2017: UC Berkeley: Defense department pours $65 million into making CRISPR safer 32
Jul 19, 2017: DARPA: Building the Safe Genes Toolkit 34
Jul 12, 2017: Anti-CRISPR proteins decrease off-target side effects of CRISPR-Cas9 37
Jan 13, 2017: Scientists reprogram embryonic stem cells to expand their potential cell fates 39
Product News 41
Apr 11, 2018: New Methodology Helps Study of Promising Targeted Drug Delivery Scaffold 41
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43
List of Tables
University of California Berkeley, Pharmaceuticals & Healthcare, Key Facts 2
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of California Berkeley, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of California Berkeley, Deals By Therapy Area, 2012 to YTD 2018 8
University of California Berkeley, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MYOS RENS Technology Enters into Research Agreement with University Of California Berkley 10
Novartis Enters into Agreement with University of California 11
University of California, Berkeley Enters into Agreement with Aduro Biotech 12
Excision BioTherapeutics Enters into Licensing Agreement with University of California Berkeley 13
Aduro BioTech Amends Licensing Agreement with University of California, Berkeley 14
Aduro BioTech Enters Into Licensing Agreement With University Of California, Berkeley 15
Aduro BioTech Enters into Licensing Agreement with UCB 16
University of California Berkeley, Key Competitors 17
University of California Berkeley, Key Employees 18
University of California Berkeley, Subsidiaries 19
List of Figures
University of California Berkeley, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of California Berkeley, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
